Millipore adds water purification system for ion chromatography
The system improves baseline stability and reduces downtime in Dionex IC equipment.
Millipore of Billerica, MA, US, says ultrapure water from the ICW-3000 system increases the precision of IC analyses.
The ICW-3000 system provides a continual flow of ultrapure water to the eluent generator and regenerant lines of the suppressor. This reduces the carbonate content in the water - sharply decreasing contamination risks and improving experiment reproducibility, while also removing the need for helium. The water system also eliminates the need for eluent preparation and the instrument downtime that occurs when filling eluent bottles.
With only two tubes and one power cord to connect, the system simple to install. Everyday use is also easy. The user just fills the system's 10-litre tank with pure water in order to produce a constant flow of ultrapure water for the IC system. The ICW-3000 system is remote-controlled by the Dionex IC system and both systems are fully compatible.
You may also like
Trending Articles
You may also like
Manufacturing
BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech
The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Analysis
Introducing Shimadzu’s MultiNA II: Redefining precision in life science analysis
Designed with users in mind, the MultiNA II MCE-301 is a fully automated microchip electrophoresis system designed to accelerate and simplify genetic analysis workflows in pharmaceutical and biopharmaceutical laboratories
Manufacturing
Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform
The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing
Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market
Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA